Basil Systems Commercial Launch
and New Seed Funding
Basil Systems is delighted to announce our SaaS platform for delivering essential healthcare insights is now commercially available. In addition, we secured $1.5M in venture capital funding to accelerate development and drive our initial market launch.
Susan Alpert, a top regulatory consultant, former SVP of Regulatory Affairs at Medtronic and a former FDA Director, was unequivocal in her enthusiasm for our new platform, saying, “Basil Systems is a game changer!”
The funding round was led by Looking Glass Capital and Golden Ventures, with participation from Predictive VC.
Read the full press release here.